Presenting Author: Awa Diop
@@@ Denis Talbot – Department of social and preventive medicine, Laval University ### 1360377###Co-Author######Department of social and preventive medicine, Laval University###Co-Author: Denis Talbot – Department of social and preventive medicine, Laval University
@@@ Caroline Sirois, PhD – Laval University ### 1358295###Co-Author######Laval University###Co-Author: Caroline Sirois, PhD – Laval University
L-1EPresenting Author: Wael Khawagi – Taif University
@@@ Douglas Steinke – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK ### 1086970###Co-Author######Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK###Co-Author: Douglas Steinke – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
@@@ Matthew Carr – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK ### 1359972###Co-Author######Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK###Co-Author: Matthew Carr – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
@@@ Alison Wright – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK ### 1359973###Co-Author######Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK###Co-Author: Alison Wright – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
@@@ Darren M. Ashcroft – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK ### 1358093###Co-Author######Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK###Co-Author: Darren M. Ashcroft – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
@@@ Anthony Avery – Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, UK ### 1359974###Co-Author######Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, UK###Co-Author: Anthony Avery – Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, UK
@@@ Richard Keers – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK ### 1359975###Co-Author######Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK###Co-Author: Richard Keers – Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK
L-3JPresenting Author: Ya-Hui Yu – McGill University
@@@ Robert W. Platt – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada ### 1358167###Co-Author###Full Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada###Co-Author: Robert W. Platt – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
@@@ Oriana Hoi Yun Yu, MD, MSc – Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Québec, Canada ### 1360448###Co-Author######Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Québec, Canada###Co-Author: Oriana Hoi Yun Yu, MD, MSc – Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Québec, Canada
@@@ Kristian B. Filion – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada ### 1062622###Co-Author###Associate Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada###Co-Author: Kristian B. Filion – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
OP-17BPresenting Author: Lars J. Kjerpeseth – Norwegian Institute of Public Health
@@@ Carolyn E. Cesta, PhD – Karolinska Institutet ### 1062759###Co-Author###postdoctoral fellow###Karolinska Institutet###Co-Author: Carolyn E. Cesta, PhD – Karolinska Institutet
@@@ Anders Engeland – University of Bergen ### 1360122###Co-Author######University of Bergen###Co-Author: Anders Engeland – University of Bergen
@@@ Kari Furu – Norwegian Institute of Public Health ### 1063219###Co-Author######Norwegian Institute of Public Health###Co-Author: Kari Furu – Norwegian Institute of Public Health
@@@ Mika Gissler – Finnish Institute for Health and Welfare ### 1360036###Co-Author######Finnish Institute for Health and Welfare###Co-Author: Mika Gissler – Finnish Institute for Health and Welfare
@@@ Hanne L. Gulseth – Norwegian Institute of Public Health ### 1360123###Co-Author######Norwegian Institute of Public Health###Co-Author: Hanne L. Gulseth – Norwegian Institute of Public Health
@@@ Øystein Karlstad – Norwegian Institute of Public Health ### 1358431###Co-Author######Norwegian Institute of Public Health###Co-Author: Øystein Karlstad – Norwegian Institute of Public Health
@@@ Helle Kieler – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1360033###Co-Author######Centre for Pharmacoepidemiology, Karolinska Institutet###Co-Author: Helle Kieler – Centre for Pharmacoepidemiology, Karolinska Institutet
@@@ Maarit K. Leinonen – Finnish Institute for Health and Welfare ### 1358190###Co-Author######Finnish Institute for Health and Welfare###Co-Author: Maarit K. Leinonen – Finnish Institute for Health and Welfare
@@@ Mette Nørgaard – Department of Clinical Epidemiology, University of Aarhus ### 1063034###Co-Author######Department of Clinical Epidemiology, University of Aarhus###Co-Author: Mette Nørgaard – Department of Clinical Epidemiology, University of Aarhus
@@@ Laura Pazzagli – Karolinska Institutet ### 1358376###Co-Author######Karolinska Institutet###Co-Author: Laura Pazzagli – Karolinska Institutet
@@@ Randi M. Selmer – Norwegian Institute of Public Health, Oslo, Norway ### 1360226###Co-Author######Norwegian Institute of Public Health, Oslo, Norway###Co-Author: Randi M. Selmer – Norwegian Institute of Public Health, Oslo, Norway
@@@ Helga Zoega – Centre for Big Data Research in Health, UNSW Sydney ### 1358124###Co-Author######Centre for Big Data Research in Health, UNSW Sydney###Co-Author: Helga Zoega – Centre for Big Data Research in Health, UNSW Sydney
@@@ Jacqueline M. Cohen, PhD – Norwegian Institute of Public Health ### 1360547###Co-Author######Norwegian Institute of Public Health###Co-Author: Jacqueline M. Cohen, PhD – Norwegian Institute of Public Health
OP-17FPresenter: Hui Lee Wong, PhD – US Food and Drug Administration
@@@ Xabier Garcia de Albeniz – RTI Health Solutions ### 1062596###Presenter######RTI Health Solutions###Presenter: Xabier Garcia de Albeniz – RTI Health Solutions
@@@ Anne Mobley Butler, PhD – Washington University School of Medicine ### 1062638###Presenter###Assistant Professor###Washington University School of Medicine###Presenter: Anne Mobley Butler, PhD – Washington University School of Medicine
@@@ Heather J. Whitaker ### 1360253###Presenter#########Presenter: Heather J. Whitaker
@@@ Marc A. Suchard – University of California, Los Angeles ### 1360254###Presenter######University of California, Los Angeles###Presenter: Marc A. Suchard – University of California, Los Angeles
WS-09Presenting Author: Yasser Albogami, PhD – King Saud University
@@@ Almut G. Winterstein, PhD – Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida ### 1302738###Co-Author######Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida###Co-Author: Almut G. Winterstein, PhD – Department of Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, College of Pharmacy, University of Florida
SP06BCo-Author: Cherise Wong – Regeneron Pharmaceuticals
@@@ Caitlin Knox – Regeneron Pharmaceuticals ### 1360272###Co-Author######Regeneron Pharmaceuticals###Co-Author: Caitlin Knox – Regeneron Pharmaceuticals
@@@ Wenzhen Ge – Regeneron Pharmaceuticals ### 1360273###Co-Author######Regeneron Pharmaceuticals###Co-Author: Wenzhen Ge – Regeneron Pharmaceuticals
@@@ Ning Wu – Regeneron Pharmaceuticals ### 1360274###Co-Author######Regeneron Pharmaceuticals###Co-Author: Ning Wu – Regeneron Pharmaceuticals
@@@ Andrea Marcus – Regeneron Pharmaceuticals ### 1063148###Co-Author######Regeneron Pharmaceuticals###Co-Author: Andrea Marcus – Regeneron Pharmaceuticals
@@@ Jessica Jalbert, PhD – Regeneron Pharmaceuticals ### 1062874###Co-Author######Regeneron Pharmaceuticals###Co-Author: Jessica Jalbert, PhD – Regeneron Pharmaceuticals
@@@ Asieh Golozar, MD, PhD, MHS, MPH – Regeneron Pharmaceuticals ### 1062692###Presenting Author######Regeneron Pharmaceuticals###Presenting Author: Asieh Golozar, MD, PhD, MHS, MPH – Regeneron Pharmaceuticals
L-3BPresenting Author: Tiansheng Wang – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
@@@ Michael Kosorok – University of North Carolina at Chapel Hill ### 1359686###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Michael Kosorok – University of North Carolina at Chapel Hill
@@@ Alexander Keil – University of North Carolina at Chapel Hill ### 1358641###Co-Author######University of North Carolina at Chapel Hill###Co-Author: Alexander Keil – University of North Carolina at Chapel Hill
@@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA ### 1360328###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA###Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
@@@ Michele Jonsson Funk – University of North Carolina at Chapel Hill ### 1046824###Co-Author###Associate Professor###University of North Carolina at Chapel Hill###Co-Author: Michele Jonsson Funk – University of North Carolina at Chapel Hill
@@@ John Buse – University of North Carolina at Chapel Hill ### 1397960###Co-Author######University of North Carolina at Chapel Hill###Co-Author: John Buse – University of North Carolina at Chapel Hill
@@@ Til Stürmer – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1062525###Co-Author######Department of Epidemiology, University of North Carolina at Chapel Hill###Co-Author: Til Stürmer – Department of Epidemiology, University of North Carolina at Chapel Hill
PP-01E